Table 5.
Univariable and multivariable Cox regression analysis for overall survival
| |
Univariable |
Multivariable |
||
|---|---|---|---|---|
| p-value | HR (95% CI) | p-value | HR (95% CI) | |
| pG |
0.053 |
|
0.293 |
|
| 1 |
0.738 (0.232 - 3.267) |
.718 (0.220 – 3.220) |
||
| 2 |
1.508 (0.545 – 6.251) |
1.191 (0.418 – 5.004) |
||
| 3 |
2.042 (1.132 – 3.922) |
1.658 (0.885 – 3.312) |
||
| TNM stage |
0.007 |
2.986 (1.394 – 5.828) |
0.015 |
2.715 (1.234 – 5.499) |
| ECLNI |
0.016 |
1.974 (1.141 – 3.361) |
0.032 |
1.870 (1.057 – 3.268) |
| PNI |
0.071 |
1.986 (0.947 – 4.879) |
0.222 |
1.680 (0.750 – 4.521) |
| ≥ 6 genes or/and TGF-β1 | 0.067 | 1.734 (0.962 – 3.132) | 0.047 | 1.366 (1.004 – 1.861) |
HR (95% CI) hazard ration with 95% confidence interval, pG tumor differentiation, pT tumor stage, ECLNI extracapsular lymph node involvement, PNI perineural invasion.